Validating the Sensitivity of High-Resolution Melting Analysis for JAK2 V617F Mutation in the Clinical Setting-Reference-Cited by-同舟云学术

Validating the Sensitivity of High-Resolution Melting Analysis for JAK2 V617F Mutation in the Clinical Setting

Published:2016-05-12 Issue:6 Volume:30 Page:838-844
ISSN:0887-8013
Container-title:Journal of Clinical Laboratory Analysis
language:en
Short-container-title:J. Clin. Lab. Anal.

Author:

Lin Chien-Yu¹²³,Ho Cheng-Mao²⁴,Tamamyan Gevorg⁵,Yang Shu-Fen²³,Peng Ching-Tien⁶⁷,Chang Jan-Gowth²³⁸

Affiliation:

1. Graduate Institute of Clinical Medical Sciences; China Medical University; Taichung Taiwan

2. Department of Laboratory Medicine; China Medical University Hospital; Taichung Taiwan

3. Epigenome Research Center; China Medical University Hospital; Taichung Taiwan

4. Department of Nursing; Hungkuang University; Taichung Taiwan

5. Department of Pediatric Hemato/Oncology; Complex Clinic of Chemotherapy; Yerevan State Medical University “Muratsan” Hospital; Yerevan Armenia

6. Division of Pediatric Hemato/Oncology; China Medical University Children's Hospital; Taichung Taiwan

7. Department of Biotechnology; Asia University; Taichung Taiwan

8. College of Medicine; China Medical University; Taichung Taiwan

Funder

China Medical University Hospital

Publisher

Wiley

Subject

Microbiology (medical),Biochemistry (medical),Medical Laboratory Technology,Clinical Biochemistry,Public Health, Environmental and Occupational Health,Hematology,Immunology and Allergy

Reference28 articles.

1. Spontaneous STAT5 activation induces growth factor independence in idiopathic myelofibrosis: Possible relationship with FKBP51 overexpression;Komura;Exp Hematol,2003

2. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera;James;Nature,2005

3. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders;Baxter;Lancet,2005

4. Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: Recommendations from an ad hoc international expert panel;Tefferi;Blood,2007

5. Diagnostic assays for the JAK2 V617F mutation in chronic myeloproliferative disorders;Greiner;Am J Clin Pathol,2006

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Effect of DNA Concentration on the HRM Performance in Detecting Jak2 p.V617F Variant in Patients with Myeloproliferative Neoplasms;Current Signal Transduction Therapy;2023-07

2. Oncogenic and tumor suppressor genes expression in myeloproliferative neoplasms: The hidden side of a complex pathology;Journal of Clinical Laboratory Analysis;2022-02-17

Analysis of the reannealing- instead of melting-curve in the detection of JAK2 V617F mutation by HRM method

;Journal of Blood Medicine;2019-07

4. Development of a high resolution melting analysis assay for rapid identification of JAK2 V617F missense mutation and its validation;Experimental Hematology & Oncology;2019-04-30

5. A Comparison of Techniques to Evaluate the Effectiveness of Genome Editing;Trends in Biotechnology;2018-02